PRKAR2B and neoplasm: In prostate carcinoma cells, an increase in RIIbeta expression inhibits tumor growth, while an increase in RIalpha stimulates tumor growth [40]; in these tumors, the cAMP pathway may also interact with the androgen receptor, by enhancing its activation [49].